Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.03 USD | -4.60% |
|
-3.68% | -17.60% |
06-12 | Day One Biopharmaceuticals Insider Sold Shares Worth $378,588, According to a Recent SEC Filing | MT |
06-12 | XOMA Receives $8.1 Million Milestone Related to Sale of Priority Review Voucher | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.60% | 1.05B | |
+38.66% | 52.85B | |
+35.57% | 38.24B | |
-7.81% | 38.87B | |
-10.77% | 26.79B | |
+11.77% | 26.16B | |
-17.82% | 19.9B | |
+35.09% | 13.18B | |
+29.17% | 12.24B | |
-3.05% | 11.79B |
- Stock Market
- Equities
- DAWN Stock
- News Day One Biopharmaceuticals, Inc.
- HC Wainwright Adjusts Price Target on Day One Biopharmaceuticals to $40 From $50, Maintains Buy Rating